Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.

Silvia Antolín,Lucía García-Caballero,Cristina Reboredo,Aurea Molina Diaz,J. Mosquera,Ángel Vázquez-Boquete,Rosalía Gallego,María Paz Santiago,Ángel Concha,Maria Eva Perez,Lourdes Calvo,Tomás García-Caballero

Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.

2020

Silvia Antolín
Lucía García-Caballero
Cristina Reboredo
Aurea Molina Diaz
J. Mosquera
Ángel Vázquez-Boquete
Rosalía Gallego
María Paz Santiago
Ángel Concha
Maria Eva Perez
Lourdes Calvo
Tomás García-Caballero

e12641Background: HER2 targeted therapy in combination with chemotherapy have changed the aggressive natural history of HER2-positive tumors. To select patients to be treated with this type of agen...

Keywords:

HER2 Positive Breast Cancer
Oncology
Trastuzumab
neoadjuvant treatment
Internal medicine
Chemotherapy
Pathology
Medicine
HER2 Amplification
Targeted therapy
Natural history

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations